STRENGTHENS PROFILE IN SPECIALTY CHEMICALS SEGMENT; POSITIONS ATTRACTIVELY FOR ACCELERATED GROWTH FROM ADVANCED, HIGH-POTENTIAL CHEMISTRY PLATFORMS
Jubilant Ingrevia Limited, today announced the commissioning of a new facility at its manufacturing site for Diketene derivatives at Gajraula, Uttar Pradesh. As a global, integrated life science products and innovative solutions provider, the Company presentlyhas over 134 products & innovative solutions commercialised. With over four decades of experience, it has developed proficiency across ~35 key chemistry and technology platforms across its businesses: Specialty, Nutrition and Chemical Intermediates.
The newly commissioned facility adds additional capacity of ~2,000 TPA to produce high-value esters. This strengthening of the Diketene and derivatives platform marks a natural evolution of strategy in the Specialty Chemicalssegment. This business is pivoting towards accelerated growth and higher margins with the introduction of several downstream derivatives.
In line with its long-term strategic objectives, Jubilant Ingrevia remains committed to
commissioning of future phases of Diketene derivatives. In addition to existing clients the
expanded range of diketene derivatives will be aimed at a new category of customers in key
international markets, including the U.S and E.U regions.
